Table 1 Characteristics of the study sample

Age [years]^a

48/48

49.1 ± 8.7

57.6 ± 10.4

<0.001

sex [m]^b

48/48

33 (68.8)

29 (60.4)

0.522

BMI [kg/m²]^a

45/47

27 ± 4.4

28.4 ± 4.1

0.102

Waist [cm]^a

41/45

91.6 ± 13.3

100.6 ± 10.1

<0.001

SBP [mmHg]^a

32/34

127.2 ± 10.7

132.7 ± 18.2

0.132

DBP [mmHg]^a

32/34

80.8 ± 8.8

80.1 ± 11.2

0.764

TC [mg/dl]^c

48/48

214.5 (181.5–273.0)

217.5 (183.5–272.8)

0.980

LDL-C [mg/dl]^c

46/45

116.4 (95.8–168.5)

120.0 (98.0–169.1)

0.730

HDL-C [mg/dl]^c

46/44

45.5 (38.5–63.0)

49.0 (38.3–61.0)

0.878

NHDL-C [mg/dl]^c

46/44

159.0 (130.5–204.8)

158.0 (134.0–207.5)

0.881

ln(TG)^a

48/48

5.3 ± 0.8

5.4 ± 0.7

0.380

ln(Lip.a)^c

42/43

2,89 (2.30–3.29)

3.47 (2.30–4.34)

0.052

IMT-left [mm]^c

43/43

0.57 (0.51–0.66)

0.63 (0.58–0.75)

0.009

IMT-right [mm]^a

40/43

0.60 ± 0.10

0.67 ± 0.15

0.013

IMT-av [mm]^a

40/43

0.60 ± 0.09

0.68 ± 0.14

0.002

Glucose [mg/dl]^a

48/46

88.1 ± 6.6

100.1 ± 10.8

<0.001

Insulin [μU/ml]^a

46/44

8.98 ± 5.6

12.1 ± 9.7

0.069

C-Pept [ng/ml]^c

38/39

2.10 (1.68–2.85)

2.70 (2.30–3.80)

0.012

HbA1c [%]^a

48/47

5.3 ± 0.24

5.8 ± 0.33

<0.001

HOMA-IR^a

39/39

1.95 ± 1.3

2.5 ± 1.8

0.120

QUICKI^c

39/39

0.35 (0.33–0.40)

0.34 (0.31–0.38)

0.248

ln(proBNP) [pg/ml]^c

43/39

3.87 (3.31–4.41)

4.14 (3.34–4.73)

0.370

ln(hsCRP) [mg/d]^a

45/45

−1.97 ± 1.26

−1.90 ± 0.97

0.764

CVD^b

46/45

6 (13.0)

11 (24.4)

0.188

Mean steps/7d^c

38/38

6969 (5904–9092)

7707 (6145–9860)

0.747

CRP [mg/dl]^c

45/45

0.14 (0.09–0.40)

0.16 (0.09–0.34)

0.904

smoking [PY]^c

36/34

15.0 (0.0–27.3)

5.5 (0.0–27.8)

0.511

Bezafibrate [dd (mg)]^c

14/10

400 (400–400)

400 (400–400)

0.379

Rosuvastatin [dd (mg)]^c

15/23

10 (10–20)

20 (10–20)

0.394

Atorvastatin [dd (mg)]^c

4/4

60 (32.5–80)

30 (17.5–50)

0.743

Simvastatin [dd (mg)]^c

5/8

20 (20–20)

20 (20–80)

0.314

Ezetimibe [n(%)]^b

4/5

4 (9.3)

5 (11.9)

0.697

Nicotinic Acid [n(%)]^b

3/2

3 (7.0)

2 (4.8)

0.664

Mean treatment duration of the last taken dyslipidemic medication (days)^c

46/46

774 (338.50–2331.25)

1418.50 (512.75–3168.50)

0.199